what was the gist of the article? cant get access as it's a paid subscription.
annual report due by the 31st. maybe after this the board can get to work on some promotion.
comparable nasdaq companies are valued in a different stratosphere. fingers crossed some promotion efforts will be made overseas.
http://www.copyright link/business/...ss-out-on-big-biotech-returns-20150820-gj47rc
